Brief: Nymox Pharmaceutical Completes All Required Tasks For Planned Upcoming Regulatory Submission For Fexapotide Triflutate For Treatment Of BPH
13/12/2021 14:42
Dec 13 (Reuters) - Nymox Pharmaceutical Corp NYMX.O :
* NYMOX PHARMACEUTICAL - COMPLETED ALL REQUIRED TASKS FOR
PLANNED
UPCOMING REGULATORY SUBMISSION FOR FEXAPOTIDE TRIFLUTATE FOR
TREATMENT OF BPH
Source text for Eikon: ID:nGNX58Sw0D
Further company coverage: NYMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba